August Group Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$986K Sell
822
-31
-4% -$31.7K 1.08% 21
2026
Q1
$785K Sell
853
-4
-0.5% -$4.05K 0.91% 25
2025
Q4
$921K Buy
+857
New +$819K 1.02% 23

Other funds holding LLY

August Group Capital's LLY Position: Q2 2026 in Review

August Group Capital reduced its Eli Lilly (LLY) stake by 3.6% in Q2 2026, selling an estimated $31.7K and leaving 822 shares worth $986K. The position accounts for 1.08% of the portfolio, ranked #21.

August Group Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • August Group Capital held 822 shares of Eli Lilly worth $986K as of Q2 2026.
  • August Group Capital sold 31 Eli Lilly shares in Q2 2026, an estimated $31.7K.
  • Eli Lilly made up 1.08% of August Group Capital's portfolio in Q2 2026, its #21 holding.
  • August Group Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on August Group Capital's 13F filing for Q2 2026, filed 11 Aug 2026.